INS and metabolic dysfunction-associated steatotic liver disease: Insulin resistance, resulting from long-term, sustained hyperglycemia, leading to impaired insulin-stimulated glucose utilization and glycogen synthesis, is the key pathogenic feature of metabolic syndrome and is now regarded as the most common risk factor for the development and progression of nonalcoholic fatty liver disease (NAFLD) [7].